OMICS International

International Conferences

Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 1000+ Conferences, 1000+ Symposiums and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series Ltd: World’s leading Event Organizer

 

Recommended Conferences for Medicines for Anxiety

Medicines for Anxiety


Omics International publishes 304 Open Access Articles in 13 International Journals it has 32 Upcoming Conferences and 15 Previous Conferences with 581 Conference Proceedings and 92 National symposiums

Anxiety disorders develop from a complex set of risk factors, including genetics, brain chemistry, personality, and life events. Anxiety is a normal response to stress, worry or threat – but when it is very severe, long-lasting, or out of proportion to the circumstances, it becomes known as an anxiety disorder. There are several different types of anxiety disorder: for example, generalised anxiety disorder, social anxiety disorder, panic disorder and obsessive–compulsive disorder. By affecting a person’s mood, thoughts and behaviour, an anxiety disorder can make it difficult to cope with daily life at home, at work or school, and when socialising. The cause of anxiety disorders is not known, however, certain alterations in brain functions have been shown to be implicated in various anxiety disorders.  In addition, social conditions and stresses may contribute to the risk of developing an anxiety disorder.

OMICS International through its Open access initiatives is committed to make genuine and reliable contributions to the scientific community by publishing research work and conference paper related to such disorders. It is known that OMICS Group hosts over 700 edge peer reviewed Open Access Journals and organizes over more than 1000 Global Events annually. Its publishing group journals have over 5 million readers and the fame and success of the same can be attributed to the strong editorial board which contains over 75000+ eminent personalities that ensure a quality and quick review process checker. 

Anxiety disorders are the most common mental illness in the U.S, affecting 40 million adults in the United States age 18 and older, or 18% of the population. Anxiety disorders are highly treatable, yet only about one-third of those suffering receive treatment. Anxiety disorders cost the U.S. more than $42 billion a year, almost one-third of the country's $148 billion total mental health bill, according to "The Economic Burden of Anxiety Disorders. More than $22.84 billion of those costs are associated with the repeated use of health care services. Clinical anxiety affected around 10 percent of people in North America, Western Europe, and Australia/New Zealand compared to about 8 percent in the Middle East and 6 percent in Asia. Both major depression and anxiety are found more commonly in women than in men.Anxiety the most common of all mental disorders currently affects about one in 13 people (7.3 percent). Approximately 12% of Canadians are affected by anxiety disorders that cause mild to severe impairment in daily living, and more than one in four Canadian workers report being highly stressed. In this session, experienced lawyers will join a mental health expert to discuss ways to monitor and reduce workplace stress and to accommodate employees living with anxiety disorders. It has been estimated that anxiety disorders affect between 5 and 7% of the general population, and that up to 29% of people will suffer from an anxiety disorder at least once during their lifetime.1 In 2004, over 28 million people worldwide had obsessive–compulsive disorder, and over 30 million experienced panic disorder. Anxiety disorders affect both men and women across the world, but the burden of the disease is greater in women than in men. Anxiety is the most common mental illness in the U.S, affecting 40 million adults in the United States age 18 and older, or 18% of the population. Anxiety disorders are highly treatable, yet only about one-third of those suffering receive treatment. Anxiety disorders cost the U.S. more than $42 billion a year, almost one-third of the country's $148 billion total mental health bill, according to "The Economic Burden of Anxiety Disorders. More than $22.84 billion of those costs are associated with the repeated use of health care services. Clinical anxiety affected around 10 percent of people in North America, Western Europe, and Australia/New Zealand compared to about 8 percent in the Middle East and 6 percent in Asia. Both major depression and anxiety are found more commonly in women than in men. Anxietythe most common of all mental disorders currently affects about one in 13 people (7.3 percent). Approximately 12% of Canadians are affected by anxiety disorders that cause mild to severe impairment in daily living, and more than one in four Canadian workers report being highly stressed. In this session, experienced lawyers will join a mental health expert to discuss ways to monitor and reduce workplace stress and to accommodate employees living with anxiety disorders.

List of Best International Conferences

JOURNALS:

Companies:

  • Leehpl Ventures
  • Nexus Life care
  • Estrellas Life Sciences Pvt
  • Luckys Pharma
  • Unibiotech Formulations
  • Zuche Pharmaceuticals
  • Health Biotech Limited
  • Macwell Pharmaceuticals

Market analysis:

The global market for therapies for depressive and anxiety disorders was $28 billion in 2008. It increased to $29.4 billion in 2009. This is projected to reach $38.5 billion in 2014 at a compound annual growth rate (CAGR) of 5.6% Sales in antidepressants products were nearly $15.4 billion in 2008. It increased to $16.2 billion in 2009. This market is projected to reach $21.2 billion in 2014, for a 5-year CAGR of 5.5%. Sales in antianxiety drugs were nearly $12.6 billion in 2008. It increased to $13.2 billion in 2009. This market is projected to reach $17.3 billion in 2014, for a 5-year CAGR of 5.6%. According to a new market report published by Transparency Market Research “Anxiety Disorders and Depression Treatment Market – Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends and Forecast, 2014 – 2020”, the global anxiety disorders and depression treatment market was valued at USD 22.5 billion in 2013 and is expected to reach USD 18.2 billion in 2020, at a CAGR of (1.25%) from 2014 to 2020.  The U.S. accounted for the highest share of the revenue for each drug class due to the presence of one or more branded formulations that influenced the market dynamics significantly. However, the anxiety disorders and depression treatment market in the U.S. is currently saturated due to the presence of cheap generic products and several antidepressant drugs available on prescription for the same indication.

Anxiety is an unpleasant state of inner turmoil which is accompanied by nervous behavior. It is the subjectively unpleasant feelings of dread over anticipated events. Anxiety is the expectation of future threat rather than normal kind of fear. It is a feeling of frighten, tension and depression, usually generalized and unfocused as an overreaction to a situation that is only subjectively seen as menacing. Anxiety is often accompanied by muscular fatigue, problems in concentrating and restlessness. Anxiety can be appropriate. In case it is too much and continues for a longer period of time, the individual may suffer from an anxiety disorder. Medication can relieve the problem associated with anxiety. However it is often accomplished with side effects and safety concerns which also include the risk of addiction. Treatment with non-drug may not relieve your anxiety.

Its effectiveness is also considered as quickly as meditation but they may take quite longer period of time to show its effect. It is always suggestible to talk to you doctor in order to decide whether anxiety medication will be beneficial for an individual or not. After researching your own option which includes other therapies and lifestyle changes that may help, we can make an informed decision. Many different types of medications are being used in the treatment of anxiety disorders which also include traditional anti-anxiety drugs like antidepressants and beta-blockers. These medications can be very effective. However, they shouldn’t be thought of as a cure.

Medicines for Anxiety can provide temporary relief, but it fails to treat the underlying cause of the anxiety disorder. Also if you stop taking the drug, symptoms for anxiety may return in full force. There is necessity to be aware of the risks of anxiety medication. Medicine for Anxiety can cause a wide range of unpleasant and sometimes dangerous side effects. Too many medications for anxiety are also habit forming and physically addictive which makes it difficult to stop taking them once an individual has started. In case of severe anxiety where anxiety is actually interfering with the normal body function, medication may be the right option. But many people use anti-anxiety medication which includes therapy, yoga, exercise and self-help strategies would work well enough to reduce the side effects and risks. Medication therapy can help you to get to the bottom of your underlying issues and develop the tools to beat anxiety for good.

However, other effective treatment approaches that can be taken in addition to or instead of medications. Evaluation of the way to treat anxiety should be completely taken by the patient. The Anti-anxiety drugs like benzodiazepines which work by reducing brain activity are not recommended by doctors. This is because they may temporarily relieve anxiety, but they can also lead to unwanted side effects. Higher the dose more pronounced these side effects typically become. Some people feel sleepy, tired and uncomfortable even on low doses of benzodiazepines. It can cause problems with work and other everyday activities. The medication can build up in the body when used over longer periods of time because benzodiazepines are metabolized slowly which often results in over sedation. That is why; people who are over sedated may look like they’re drunk.

OMICS Group International Conferences is proud to host around 300 international scientific conferences around the globe to address the current issues and discoveries in the field of Medical, Immunology & Microbiology, Clinical, Material Science, Agri, Food ,Aqua, Neuroscience, Mass media, Business and Management, EEE, Chemistry, Physics, Genetics and Molecular Biology, Nursing and Health care, Pharma, Chemical Engineering and Veterinary sciences. We have largest gathering of the scientific researcher’s community across the globe with hands on expertise in conducting events and scientific sessions such as keynote presentation, oral presentation, poster presentations, worldclass exhibitions, International symposiums highly enriched International workshops which helps our attendees to learn the recent advancement of their topic of interest and also helps in growing the scientific partnership among the participants.

Conferences and workshops

•           14th International Forum on Mood and Anxiety Disorder (IFMAD 2014)

•           Depression, Anxiety and Stress

Associations

•           Social Anxiety Association

•           Anxiety and Depression Association America

•           National Anxiety Disorders Organisation

Top 10 companies for anxiety medications

•           abilify

•           seroquel

•           zyprexa

•           Seroquel XR

•           Geodon

•           Olanzapine

•           Risperdal consta

•           Invega sustenna

•           Invega

•           Zyprexa zydis

This page will be updated regularly.

This page was last updated on 11th Sep, 2015

Conferenceseries Destinations

Contact Us

Medical Conferences
Jessie Grace
jessie.grace@conferenceseries.com
1-702-508-5200 Ext:8031, 8041

Pharmaceutical Conferences
Badoni Victor
badoni.victor@conferenceseries.com
1-702-508-5200 Ext:8045, 8047

Immunology & Microbiology Conferences
Walker Smith
walker.smith@conferenceseries.com
1-702-508-5200 Ext:8031

Cancer Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Nursing and Healthcare Conferences
Jennifer Leny
jennifer.leny@conferenceseries.com
1-702-508-5200 Ext:8044

Diabetes Conferences
Stanley knight
stanley.knight@conferenceseries.com
1-702-508-5200 Ext:8040

Neuroscience Conferences
Sandeep Kumar
sandeep@conferenceseries.com
1-702-508-5200 Ext:8034

Dental Conferences
Raul Cliff
raul.cliff@conferenceseries.com
1-702-508-5200 Ext:8039

Clinical and Biochemistry Conferences
Rohit Casper
rohit.casper@conferenceseries.com
1-702-508-5200 Ext:8033

Biotechnology Conferences
Ravi Vittal
ravi.vittal@conferenceseries.com
1-702-508-5200 Ext:8031, 8037

Material Science Conferences
Lucy Grey
lucygrey@conferenceseries.com
1-702-508-5200 Ext:8035

Genetics & Mol Biology Conferences
Stephen Bruce
stephen.bruce@conferenceseries.com
1-702-508-5200 Ext:8038

Engineering Conferences
Dolly A
dolly@conferenceseries.com
+1-702-508-5200 Ext:8051

Program Enquiries
Symposia/Workshops
Sponsorships
Media Partners | Advertising